Gamma Knife Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032

Description

Persistence Market Research has recently released a comprehensive report on the global Gamma Knife Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

Gamma Knife Market Size (2025E): US$ 468.0 Mn
Projected Market Value (2032F): US$ 692.0 Mn
Global Market Growth Rate (CAGR 2025 to 2032): 5.7%

Gamma Knife Market - Report Scope:

The gamma knife market encompasses advanced stereotactic radiosurgery systems used for the non-invasive treatment of brain tumors, neurological disorders, vascular malformations, and other intracranial conditions. Gamma knife technology delivers highly focused gamma radiation beams with exceptional precision, minimizing damage to surrounding healthy tissues. The market is experiencing steady growth due to increasing prevalence of neurological diseases, rising demand for minimally invasive procedures, and continuous technological advancements in radiosurgery systems. The growing aging population and expanding adoption of precision oncology are further supporting the demand for gamma knife systems across hospitals and specialty treatment centers globally.

Market Growth Drivers:

Several key factors are fueling the growth of the global gamma knife market. The increasing incidence of neurological disorders such as brain tumors, trigeminal neuralgia, epilepsy, and arteriovenous malformations is significantly driving demand for advanced radiosurgery solutions. Growing preference for minimally invasive treatment procedures, which offer reduced recovery time and fewer post-surgical complications, is further boosting market adoption. Technological advancements in imaging, AI-assisted treatment planning, and radiation delivery systems are improving treatment accuracy and patient outcomes. Additionally, rising healthcare investments and growing awareness regarding non-invasive neurosurgical procedures are contributing to sustained market expansion globally.

Market Restraints:

Despite its promising growth potential, the gamma knife market faces several challenges. High installation and operational costs associated with gamma knife systems can limit adoption, particularly among small and mid-sized healthcare facilities. The requirement for highly skilled professionals and specialized infrastructure may also create barriers for market expansion. Additionally, limited reimbursement coverage in certain regions and the availability of alternative treatment technologies such as proton therapy and cyberknife systems may restrict market growth. Regulatory approval complexities and maintenance expenses further add to the challenges faced by manufacturers and healthcare providers.

Market Opportunities:

The gamma knife market presents significant growth opportunities driven by advancements in precision medicine and expanding healthcare infrastructure in emerging economies. Increasing investments in cancer treatment centers and neurology-focused healthcare facilities are expected to create strong demand for advanced radiosurgery systems. Emerging markets in Asia Pacific and Latin America offer substantial growth potential due to improving healthcare accessibility and rising patient awareness. Furthermore, innovation in AI-based treatment planning, robotic integration, and enhanced imaging technologies is expected to improve treatment efficiency and create new opportunities for market players. Strategic collaborations between medical device manufacturers and healthcare institutions are also anticipated to accelerate market growth over the forecast period.

Key Questions Answered in the Report:

What are the primary factors driving the global gamma knife market's growth?
Which regions and market segments are experiencing the highest demand for gamma knife systems?
How are technological advancements in radiosurgery influencing market dynamics?
Who are the key players in the gamma knife market, and what strategies are they adopting to stay competitive?
What are the emerging trends and future projections for the global gamma knife market?

Competitive Intelligence and Business Strategy:

Leading companies in the global gamma knife market are focusing on technological innovation, strategic collaborations, and product portfolio expansion to strengthen their market presence. Manufacturers are investing in AI-enabled imaging and treatment planning technologies to improve precision and treatment outcomes. Companies are also emphasizing partnerships with hospitals and specialty clinics to expand installations and improve patient accessibility. Expansion into emerging markets, along with ongoing research and development activities, is enabling market players to enhance their competitive position. Continuous advancements in frameless radiosurgery systems and improved radiation delivery techniques are further contributing to market differentiation.

Companies Covered in This Report:

Elekta AB
Varian Medical Systems
Nordion Inc.
Huiheng Medical, Inc.
ET Medical Group
American Shared Hospital Services
Masep Infini Global, Inc.
Hokai Medical Technology
Cyber Medical Corporation Ltd.
Accuray Incorporated
Brainlab AG
Elekta Korea Ltd.
ZAP Surgical Systems Inc.
IntraOp Medical Corporation
Stryker Corporation

Market Segmentation

By Device Range

High-End Gamma Knife
Medium Gamma Knife
Low Gamma Knife

By Disease Indication

Brain Metastasis
Arteriovenous Malformation (AVM)
Malignant & Benign Tumors
Trigeminal Neuralgia
Vascular Disorders
Ocular Diseases
Others

By End-user

Hospitals
Ambulatory Service Centers
Specialty Clinics

By Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Rest of Europe
East Asia
China
Japan
South Korea
South Asia & Oceania
India
Southeast Asia
Australia & New Zealand
Rest of SEO
Latin America
Brazil
Mexico
Rest of LA
Middle East & Africa
GCC Countries
South Africa
Northern Africa
Rest of MENA

Product Code: PMRREP3742

1. Executive Summary

1.1. Global Gamma Knife Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Key Trends
2.3. Macro-economic Factors
- 2.3.1. Global Sectoral Outlook
- 2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Tool Adoption Analysis
3.2. Regulatory Landscape
3.3. Value Chain Analysis
3.4. PESTLE Analysis
3.5. Porter's Five Force Analysis

4. Price Analysis, 2024A

4.1. Key Highlights
4.2. Key Factors Impacting Deployment Costs
4.3. Pricing Analysis, By Disease Indication

5. Global Gamma Knife Market Outlook

5.1. Key Highlights
- 5.1.1. Market Volume (Units) Projections
- 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
- 5.1.3. Absolute $ Opportunity
5.2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast
- 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
- 5.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
5.3. Global Gamma Knife Market Outlook: Technology
- 5.3.1. Introduction / Key Findings
- 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Technology, 2019-2024
- 5.3.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Technology, 2025-2032
  - 5.3.3.1. High-End Gamma Knife
  - 5.3.3.2. Medium Gamma Knife
  - 5.3.3.3. Low Gamma Knife
- 5.3.4. Market Attractiveness Analysis: Technology
5.4. Global Gamma Knife Market Outlook: Disease Indication
- 5.4.1. Introduction / Key Findings
- 5.4.2. Historical Market Size (US$ Mn) Analysis, By Disease Indication, 2019-2024
- 5.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
  - 5.4.3.1. Brain Metastasis
  - 5.4.3.2. Arteriovenous Malformation (AVM)
  - 5.4.3.3. Malignant & Benign Tumors
  - 5.4.3.4. Trigeminal Neuralgia
  - 5.4.3.5. Vascular Disorders
  - 5.4.3.6. Ocular Diseases
  - 5.4.3.7. Others
- 5.4.4. Market Attractiveness Analysis: Disease Indication
5.5. Global Perlite Market Outlook: End-user
- 5.5.1. Introduction / Key Findings
- 5.5.2. Historical Market Size (US$ Mn) Analysis, By End-user, 2019-2024
- 5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
  - 5.5.3.1. Hospitals
  - 5.5.3.2. Ambulatory Service Centers
  - 5.5.3.3. Specialty Clinics
- 5.5.4. Market Attractiveness Analysis: End-user

6. Global Gamma Knife Market Outlook: Region

6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019-2024
6.3. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia and Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region

7. North America Gamma Knife Market Outlook

7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Technology
- 7.2.3. By Disease Indication
- 7.2.4. By End-user
7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. U.S.
- 7.3.2. Canada
7.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Technology, 2025-2032
- 7.4.1. High-End Gamma Knife
- 7.4.2. Medium Gamma Knife
- 7.4.3. Low Gamma Knife
7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
- 7.5.1. Brain Metastasis
- 7.5.2. Arteriovenous Malformation (AVM)
- 7.5.3. Malignant & Benign Tumors
- 7.5.4. Trigeminal Neuralgia
- 7.5.5. Vascular Disorders
- 7.5.6. Ocular Diseases
- 7.5.7. Others
7.6. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
- 7.6.1. Hospitals
- 7.6.2. Ambulatory Service Centers
- 7.6.3. Specialty Clinics
7.7. Market Attractiveness Analysis

8. Europe Gamma Knife Market Outlook

8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Technology
- 8.2.3. By Disease Indication
- 8.2.4. End-user
8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. Germany
- 8.3.2. France
- 8.3.3. U.K.
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Turkey
- 8.3.8. Rest of Europe
8.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Technology, 2025-2032
- 8.4.1. High-End Gamma Knife
- 8.4.2. Medium Gamma Knife
- 8.4.3. Low Gamma Knife
8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
- 8.5.1. Brain Metastasis
- 8.5.2. Arteriovenous Malformation (AVM)
- 8.5.3. Malignant & Benign Tumors
- 8.5.4. Trigeminal Neuralgia
- 8.5.5. Vascular Disorders
- 8.5.6. Ocular Diseases
- 8.5.7. Others
8.6. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
- 8.6.1. Hospitals
- 8.6.2. Ambulatory Service Centers
- 8.6.3. Specialty Clinics
8.7. Market Attractiveness Analysis

9. East Asia Gamma Knife Market Outlook

9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Technology
- 9.2.3. By Disease Indication
- 9.2.4. By End-user
9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
9.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Technology, 2025-2032
- 9.4.1. High-End Gamma Knife
- 9.4.2. Medium Gamma Knife
- 9.4.3. Low Gamma Knife
9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
- 9.5.1. Brain Metastasis
- 9.5.2. Arteriovenous Malformation (AVM)
- 9.5.3. Malignant & Benign Tumors
- 9.5.4. Trigeminal Neuralgia
- 9.5.5. Vascular Disorders
- 9.5.6. Ocular Diseases
- 9.5.7. Others
9.6. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
- 9.6.1. Hospitals
- 9.6.2. Ambulatory Service Centers
- 9.6.3. Specialty Clinics
9.7. Market Attractiveness Analysis

10. South Asia & Oceania Gamma Knife Market Outlook

10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Technology
- 10.2.3. By Disease Indication
- 10.2.4. By End-user
10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. India
- 10.3.2. Southeast Asia
- 10.3.3. ANZ
- 10.3.4. Rest of South Asia & Oceania
10.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Technology, 2025-2032
- 10.4.1. High-End Gamma Knife
- 10.4.2. Medium Gamma Knife
- 10.4.3. Low Gamma Knife
10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
- 10.5.1. Brain Metastasis
- 10.5.2. Arteriovenous Malformation (AVM)
- 10.5.3. Malignant & Benign Tumors
- 10.5.4. Trigeminal Neuralgia
- 10.5.5. Vascular Disorders
- 10.5.6. Ocular Diseases
- 10.5.7. Others
10.6. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
- 10.6.1. Hospitals
- 10.6.2. Ambulatory Service Centers
- 10.6.3. Specialty Clinics
10.7. Market Attractiveness Analysis

11. Latin America Gamma Knife Market Outlook

11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Technology
- 11.2.3. By Disease Indication
- 11.2.4. By End-user
11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of Latin America
11.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Technology, 2025-2032
- 11.4.1. High-End Gamma Knife
- 11.4.2. Medium Gamma Knife
- 11.4.3. Low Gamma Knife
11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
- 11.5.1. Brain Metastasis
- 11.5.2. Arteriovenous Malformation (AVM)
- 11.5.3. Malignant & Benign Tumors
- 11.5.4. Trigeminal Neuralgia
- 11.5.5. Vascular Disorders
- 11.5.6. Ocular Diseases
- 11.5.7. Others
11.6. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
- 11.6.1. Hospitals
- 11.6.2. Ambulatory Service Centers
- 11.6.3. Specialty Clinics
11.7. Market Attractiveness Analysis

12. Middle East & Africa Gamma Knife Market Outlook

12.1. Key Highlights
12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
- 12.2.1. By Country
- 12.2.2. By Technology
- 12.2.3. By Disease Indication
- 12.2.4. By End-user
12.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 12.3.1. GCC Countries
- 12.3.2. Egypt
- 12.3.3. South Africa
- 12.3.4. Northern Africa
- 12.3.5. Rest of Middle East & Africa
12.4. Current Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Technology, 2025-2032
- 12.4.1. High-End Gamma Knife
- 12.4.2. Medium Gamma Knife
- 12.4.3. Low Gamma Knife
12.5. Current Market Size (US$ Mn) Analysis and Forecast, By Disease Indication, 2025-2032
- 12.5.1. Brain Metastasis
- 12.5.2. Arteriovenous Malformation (AVM)
- 12.5.3. Malignant & Benign Tumors
- 12.5.4. Trigeminal Neuralgia
- 12.5.5. Vascular Disorders
- 12.5.6. Ocular Diseases
- 12.5.7. Others
12.6. Current Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025-2032
- 12.6.1. Hospitals
- 12.6.2. Ambulatory Service Centers
- 12.6.3. Specialty Clinics
12.7. Market Attractiveness Analysis

13. Competition Landscape

13.1. Market Share Analysis, 2024
13.2. Market Structure
- 13.2.1. Competition Intensity Mapping By Market
- 13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. Elekta AB
  - 13.3.1.1. Overview
  - 13.3.1.2. Segments and Deployments
  - 13.3.1.3. Key Financials
  - 13.3.1.4. Market Developments
  - 13.3.1.5. Market Strategy
- 13.3.2. Varian Medical Systems
- 13.3.3. Nordion Inc.
- 13.3.4. Huiheng Medical, Inc.
- 13.3.5. ET Medical Group
- 13.3.6. American Shared Hospital Services
- 13.3.7. Masep Infini Global, Inc.
- 13.3.8. Hokai Medical Technology
- 13.3.9. Cyber Medical Corporation Ltd.
- 13.3.10. Accuray Incorporated
- 13.3.11. Brainlab AG
- 13.3.12. Elekta Korea Ltd.
- 13.3.13. ZAP Surgical Systems Inc.
- 13.3.14. IntraOp Medical Corporation
- 13.3.15. Stryker Corporation

14. Appendix

14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations